More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

Pediatric endocrinologist Dr. Casey Berman says GLP-1s may help children reduce their risk of developing serious health ...

Patients with idiopathic intracranial hypertension who use a GLP-1 receptor agonist are less likely to experience symptoms, require medications, or undergo surgery.

More data, this time from a large observational study, are bolstering the idea that glucagon-like peptide-1 (GLP-1) receptor agonists offer neuroprotective and cerebrovascular benefits beyond what can ...

While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...

A new report from The Center for Medicine in the Public Interest (CMPI) warns that regulators are failing to stop the illegal ...

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure increasing danger of macular degeneration.

Medication paired with behavioral change support gives employers the opportunity to provide a more well-rounded approach to ...

After interviewing dozens of people on weight loss drugs like Zepbound and Ozempic, my view of GLP-1s has completely changed ...

National Weight Loss Doctor Scott Masey joined Bloom Health Club to explain what GLP-1 drugs really do, and what most people aren’t being told. “These meds don’t just help with ...

Natalie Muth, MD, MPH, RDN, is an adjunct associate professor at UCLA Fielding School of Public Health; co-founder of Namio ...

More and more research indicates that GLP-1 analogues can have a blunting effect on addictions like drugs and alcohol. Drug ...